Works about AFLIBERCEPT

Results: 355

Early Real-World Outcomes of Switching to 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration in the United Kingdom.

Published in:

Life (2075-1729), 2025, v. 15, n. 6, p. 903, doi. 10.3390/life15060903

By:

Musadiq, Muiz;
Musadiq, Mohammed;
Latif, Fozia;
Ng, Benjamin;
Azzopardi, Matthew;
Gilead, Noa;
Needham, Andrew;
Chong, Yu Jeat

Publication type:

Article

Comparison of the effects of 3 different anti-VEGF drugs on cornea thickness, lens thickness and anterior chamber depth: Case-Control Study.

Published in:

Medicine Science, 2023, v. 12, n. 1, p. 76, doi. 10.5455/medscience.2023.01.02

By:

Eski, Mehmet Tahir;
Teberik, Kuddusi;
Sezer, Taha

Publication type:

Article

Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 7, p. 2370, doi. 10.3390/jcm14072370

By:

Hatz, Katja;
Ambresin, Aude;
Schmid, Martin;
Prünte, Christian;
Barthelmes, Daniel;
Machewitz, Tobias;
Allmeier, Helmut;
Somfai, Gabor Mark

Publication type:

Article

Clinical Characteristics of Punctate Hyperfluorescence Spots in the Fellow Eye of Patients with Unilateral Macular Neovascularization with No Drusen.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 18, p. 5394, doi. 10.3390/jcm13185394

By:

Kamao, Hiroyuki;
Goto, Katsutoshi;
Date, Yuto;
Hiraki, Ryutaro;
Mizukawa, Kenichi;
Miki, Atsushi

Publication type:

Article

Inflammation and Vasculitis Related to Brolucizumab.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 17, p. 5208, doi. 10.3390/jcm13175208

By:

Campos, António;
Mota, Carolina;
Caramelo, Francisco;
Oliveira, Nuno;
Silva, Sara;
Sousa, João

Publication type:

Article

Switching to Intravitreal Brolucizumab after Ranibizumab or Aflibercept Using Treat and Extend Regimen for Neovascular Age-Related Macular Degeneration in Japanese Patients: 1-Year Results and Factors Associated with Treatment Responsiveness.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 15, p. 4375, doi. 10.3390/jcm13154375

By:

Hirayama, Kumiko;
Yamamoto, Manabu;
Honda, Shigeru;
Kyo, Akika;
Misawa, Norihiko;
Kohno, Takeya

Publication type:

Article

Short-Term Real-World Outcomes of Intensive Aflibercept Injection for Refractory Neovascular Age-Related Macular Degeneration.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 12, p. 3503, doi. 10.3390/jcm13123503

By:

Son, Wonyung;
Sagong, Min

Publication type:

Article

Switching from a Fixed Monthly Aflibercept Regimen to Bi-Monthly Brolucizumab in Refractory Cases of Neovascular Age-Related Macular Degeneration.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 12, p. 3434, doi. 10.3390/jcm13123434

By:

Kim, Minhee;
Kang, Ji Eon;
Park, Young Gun

Publication type:

Article

Real-World Experience with Brolucizumab Compared to Aflibercept in Treatment-Naïve and Therapy-Refractory Patients with Diabetic Macular Edema.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 6, p. 1819, doi. 10.3390/jcm13061819

By:

Rübsam, Anne;
Hössl, Leopold;
Rau, Saskia;
Böker, Alexander;
Zeitz, Oliver;
Joussen, Antonia M.

Publication type:

Article

Comparison of Loading Dose between Aflibercept and Faricimab for Neovascular Age-Related Macular Degeneration.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 385, doi. 10.3390/jcm13020385

By:

Hara, Chikako;
Suzue, Masaki;
Fujimoto, Satoko;
Fukushima, Yoko;
Sayanagi, Kaori;
Nishida, Kentaro;
Maruyama, Kazuichi;
Sato, Shigeru;
Nishida, Kohji

Publication type:

Article

Fixed Quarterly Dosing of Aflibercept after Loading Doses in Neovascular Age-Related Macular Degeneration in Chinese Eyes.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 145, doi. 10.3390/jcm13010145

By:

Wong, Daniel H. T.;
Li, Kenneth K. W.

Publication type:

Article

Efficacy of a Modified Treat-and-Extend Aflibercept Regimen for Macular Oedema in Eyes with Central Retinal Vein Occlusion: 2-Year Prospective Study.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 15, p. 5089, doi. 10.3390/jcm12155089

By:

Arai, Yusuke;
Takahashi, Hidenori;
Inoda, Satoru;
Sakamoto, Shinichi;
Tan, Xue;
Kawashima, Hidetoshi;
Yanagi, Yasuo

Publication type:

Article

Intravitreal Aflibercept for Patients with Acute Nonarteritic Anterior Ischemic Optic Neuropathy: A Retrospective Trial.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 14, p. 4868, doi. 10.3390/jcm12144868

By:

Cheng, Kai-Chun;
Chiu, Chien-Chih;
Chen, Kuo-Jen;
Chang, Yo-Chen

Publication type:

Article

A Multi-Modal AI-Driven Cohort Selection Tool to Predict Suboptimal Non-Responders to Aflibercept Loading-Phase for Neovascular Age-Related Macular Degeneration: PRECISE Study Report 1.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 8, p. 3013, doi. 10.3390/jcm12083013

By:

Chorev, Michal;
Haderlein, Jonas;
Chandra, Shruti;
Menon, Geeta;
Burton, Benjamin J. L.;
Pearce, Ian;
McKibbin, Martin;
Thottarath, Sridevi;
Karatsai, Eleni;
Chandak, Swati;
Kotagiri, Ajay;
Talks, James;
Grabowska, Anna;
Ghanchi, Faruque;
Gale, Richard;
Hamilton, Robin;
Antony, Bhavna;
Garnavi, Rahil;
Mareels, Iven;
Giani, Andrea

Publication type:

Article

Preliminary Study of Different Treatment Responses between Bevacizumab, Aflibercept and Dexamethasone Implant According to Renal Function in Diabetic Macular Edema Patients.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 23, p. 7047, doi. 10.3390/jcm11237047

By:

Moon, Tae Hwan;
Jo, Gwon Hui;
Seo, Eoi Jong;
Kim, Kyung Tae;
Ku, Eu Jeong;
Kwon, Soon Kil;
Kim, Jin Young;
Chae, Ju Byung;
Kim, Dong Yoon

Publication type:

Article

Comparative Effectiveness of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Managing Neovascular Age-Related Macular Degeneration: A Meta-Analysis.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 1834, doi. 10.3390/jcm11071834

By:

Matonti, Frédéric;
Korobelnik, Jean-François;
Dot, Corinne;
Gualino, Vincent;
Soler, Vincent;
Mrejen, Sarah;
Delyfer, Marie-Noëlle;
Baillif, Stéphanie;
Streho, Maté;
Gascon, Pierre;
Creuzot-Garcher, Catherine;
Kodjikian, Laurent

Publication type:

Article

Monthly Alternating Injections of Aflibercept and Bevacizumab for Neovascular Age-Related Macular Degeneration.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1543, doi. 10.3390/jcm11061543

By:

Lee, Junyeop;
Kim, You Na;
Kim, June-Gone

Publication type:

Article

Short-Term Outcomes of Switching to Ranibizumab in Polypoidal Choroidal Vasculopathy Resistant to Aflibercept Therapy.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 24, p. 5739, doi. 10.3390/jcm10245739

By:

Jeon, Young-Joon;
Kim, Jae-Hui;
Kim, Jong-Woo;
Kim, Chul-Gu

Publication type:

Article

Investigation of the Trend of Selecting Anti-Vascular Endothelial Growth Factor Agents for the Initial Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 16, p. 3580, doi. 10.3390/jcm10163580

By:

Kim, Jae-Hui;
Kim, Jong-Woo;
Kim, Chul-Gu

Publication type:

Article

Efficacy of Modified Treat-and-Extend Regimen of Aflibercept for Macular Edema from Branch Retinal Vein Occlusion: 2-Year Prospective Study Outcomes.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 14, p. 3162, doi. 10.3390/jcm10143162

By:

Arai, Yusuke;
Takahashi, Hidenori;
Inoda, Satoru;
Sakamoto, Shinichi;
Tan, Xue;
Inoue, Yuji;
Tominaga, Satoko;
Kawashima, Hidetoshi;
Yanagi, Yasuo

Publication type:

Article

Switching to Brolucizumab in Neovascular Age-Related Macular Degeneration Incompletely Responsive to Ranibizumab or Aflibercept: Real-Life 6 Month Outcomes.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 12, p. 2666, doi. 10.3390/jcm10122666

By:

Haensli, Christof;
Pfister, Isabel B.;
Garweg, Justus G.

Publication type:

Article

Effect and factors associated with reactivation after intravitreal conbercept or aflibercept in retinopathy of prematurity.

Published in:

European Journal of Medical Research, 2025, v. 30, n. 1, p. 1, doi. 10.1186/s40001-024-02206-7

By:

Huang, Chunling;
Zou, Weikang;
Ma, Wenbei;
Li, Jiali;
Bai, Yichen;
Wu, Rong;
Li, Qiqi;
Fang, Qi;
Chen, Wenna;
Lu, Xiaohe;
Feng, Songfu

Publication type:

Article

Early optical coherence tomography biomarkers for tailored frequency of intravitreal aflibercept in neovascular age-related macular degeneration.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-93962-x

By:

Lim, Gyeongsoo;
Kim, Kyung Tae;
Kim, Dong Yoon;
Chae, Ju Byung;
Seo, Eoi Jong

Publication type:

Article

Tocilizumab and Aflibercept as a Treatment Option for Refractory Macular Edema after Acute Retinal Necrosis.

Published in:

Ocular Immunology & Inflammation, 2023, v. 31, n. 1, p. 242, doi. 10.1080/09273948.2021.2024580

By:

Bograd, Alexandra;
Villiger, Peter M.;
Munk, Marion R.;
Bolt, Isabel;
Tappeiner, Christoph

Publication type:

Article

OCT Angiography Study of the Macula in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept.

Published in:

2021

By:

Dastiridou, Anna;
Karathanou, Katerina;
Riga, Paraskevi;
Anagnostopoulou, Sofia;
Balasubramanian, Siva;
Mataftsi, Asimina;
Brazitikos, Periklis;
Ziakas, Nikolaos;
Androudi, Sofia

Publication type:

journal article

Comparison of Ranibizumab versus Aflibercept in Treating Macular Edema among Patients with Serous Retinal Detachment Secondary to Branch Retinal Vein Occlusion.

Published in:

2021

By:

Küçük, Bekir;
Sirakaya, Ender;
Karaca, Cagatay

Publication type:

journal article

Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration.

Published in:

Journal of Experimental Pharmacology, 2021, v. 13, p. 905, doi. 10.2147/JEP.S259298

By:

Kaiser, Stephanie M;
Arepalli, Sruthi;
Ehlers, Justis P

Publication type:

Article

Retracted: Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema.

Published in:

2024

By:

International, Emergency Medicine

Publication type:

Correction Notice

Aflibercept Intervention in Experimental Branch Retinal Vein Occlusion Results in Upregulation of DnaJ Homolog Subfamily C Member 17.

Published in:

Journal of Ophthalmology, 2021, p. 1, doi. 10.1155/2021/6690260

By:

Cehofski, Lasse Jørgensen;
Kruse, Anders;
Alsing, Alexander Nørgård;
Sejergaard, Benn Falch;
Nielsen, Jonas Ellegaard;
Pedersen, Shona;
Muttuvelu, Danson Vasanthan;
Kirkeby, Svend;
Honoré, Bent;
Vorum, Henrik

Publication type:

Article

Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China.

Published in:

Annals of Medicine, 2023, v. 55, n. 1, p. 1, doi. 10.1080/07853890.2023.2227424

By:

Zhao, Tantai;
Li, Jiani;
Wang, Yanbin;
Guo, Xiaojian;
Sun, Yun

Publication type:

Article

Assessment of mouse VEGF neutralization by ranibizumab and aflibercept.

Published in:

PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0278951

By:

Ichiyama, Yusuke;
Matsumoto, Riko;
Obata, Shumpei;
Sawada, Osamu;
Saishin, Yoshitsugu;
Kakinoki, Masashi;
Sawada, Tomoko;
Ohji, Masahito

Publication type:

Article

The impact of retinal fluid tolerance on the outcomes of neovascular age-related macular degeneration treated using aflibercept: A real-world study.

Published in:

PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0271999

By:

Jeng, Yu-Ting;
Lai, Tso-Ting;
Lin, Chao-Wen;
Chen, Ta-Ching;
Hsieh, Yi-Ting;
Lin, Chang-Ping;
Ho, Tzyy-Chang;
Yang, Chung-May;
Yang, Chang-Hao

Publication type:

Article

Retinal oxygen saturation, vessel diameter and flicker response in eyes with specific subtypes of neovascular age-related macular degeneration during aflibercept treatment.

Published in:

PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0271166

By:

Sacu, Stefan;
Eibenberger, Katharina;
Schmidl, Doreen;
Rezar-Dreindl, Sandra;
Garhöfer, Gerhard;
Brugger, Jonas;
Buehl, Wolf;
Schmetterer, Leopold;
Schmidt-Erfurth, Ursula

Publication type:

Article

Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen.

Published in:

PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0269399

By:

Martínez-Lago, Nieves;
Cameselle García, Soledad;
Alonso de Castro, Beatriz;
Gómez-Randulfe Rodríguez, Martín I.;
Carmona Campos, Marta;
González Villarroel, Paula;
Salgado Fernández, Mercedes;
De la Cámara Gómez, Juan C.;
Romero Reinoso, Carlos;
Cousillas Castiñeiras, Antía;
Méndez Méndez, José Carlos;
Vidal Insua, Yolanda;
Fernández-Montes, Ana

Publication type:

Article

Comparison of risks of arterial thromboembolic events and glaucoma with ranibizumab and aflibercept intravitreous injection: A nationwide population‐based cohort study.

Published in:

PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0267088

By:

Chang, Yin-Hsi;
Chien, Li-Nien;
Chen, Wan-Ting;
Lin, I-Chan

Publication type:

Article

Long-term persistence with aflibercept therapy among treatment-naïve patients with exudative age-related macular degeneration in a universal health care system: a retrospective study.

Published in:

2022

By:

Angermann, Reinhard;
Franchi, Alexander;
Frede, Katharina;
Stöckl, Victoria;
Palme, Christoph;
Kralinger, Martina;
Zehetner, Claus

Publication type:

journal article

Correction: Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema.

Published in:

2022

By:

Kikuchi, Yawara;
Odashima, Yoshimi;
Yoshikawa, Kazuhiro;
Oda, Tomoyasu;
Tanaka, Fumitaka;
Oikawa, Hiroki;
Ishigaki, Yasushi;
Asahi, Koichi

Publication type:

corrected article

Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma.

Published in:

Siriraj Medical Journal, 2022, v. 74, n. 1, p. 27, doi. 10.33192/Smj.2022.4

By:

Kitnarong, Naris;
Kittipiriyakul, Janyawassamon;
Jiravarnsirikul, Anuwat

Publication type:

Article

Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy.

Published in:

Biomedicines, 2021, v. 9, n. 9, p. 1164, doi. 10.3390/biomedicines9091164

By:

Fukuda, Yoshiko;
Sakurada, Yoichi;
Matsubara, Mio;
Hasebe, Yuka;
Sugiyama, Atsushi;
Kikushima, Wataru;
Kashiwagi, Kenji

Publication type:

Article

雷珠单抗与阿柏西普玻璃体腔注射治疗渗出性年龄相关性黄斑变性的疗效观察.

Published in:

Progress in Modern Biomedicine, 2019, v. 19, n. 21, p. 4129, doi. 10.13241/j.cnki.pmb.2019.21.029

By:

龚珂;
张妍春;
孙文涛;
屈超义;
雷春灵

Publication type:

Article

A comparation of three different anti-VEGF drugs in development of persistent avascular retina in premature children.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-82445-0

By:

Ünal, Ayşe Cengiz;
Akıdan, Melih;
Erol, Muhammet Kazım

Publication type:

Article

A pilot study : retinal sensitivity change in neovascular age-related macular degeneration patients with better baseline visual acuity.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-77485-5

By:

Lee, Jae Hyup;
Yu, Hyeong Gon;
Yoon, Chang Ki

Publication type:

Article

Comparison of the efficacy and safety of SCD411 and reference aflibercept in patients with neovascular age-related macular degeneration.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65815-6

By:

Kang, Se Woong;
Choi, Jaehwan;
Sheth, Veeral S.;
Nowosielska, Agnieszka;
Misiuk-Hojlo, Marta;
Papp, András;
Brown, David M.;
Lee, Jae-Ho;
Barak, Yoreh

Publication type:

Article

Effects of switching from intravitreal injection of aflibercept to faricimab on ocular blood flow in patients with diabetic macular edema.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63435-8

By:

Saima, Yoshinari;
Yokota, Harumasa;
Kushiyama, Akifumi;
Hanaguri, Junya;
Ohno, Akira;
Takase, Koyo;
Sugiyama, Ruri;
Muranaka, Kimimasa;
Yamagami, Satoru;
Nagaoka, Taiji

Publication type:

Article

Differences between pathologic and non-pathologic high myopia in 4-year outcomes of anti-VEGF therapy for macular neovascularization.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-64456-z

By:

Honda, Yuki;
Miyata, Manabu;
Miyake, Masahiro;
Hata, Masayuki;
Numa, Shogo;
Mori, Yuki;
Ooto, Sotaro;
Tamura, Hiroshi;
Ueda-Arakawa, Naoko;
Muraoka, Yuki;
Takahashi, Ayako;
Sado, Keina;
Kido, Ai;
Tsujikawa, Akitaka

Publication type:

Article

Comparative study on the efficacy of Conbercept and Aflibercept in the treatment of neovascular age-related macular degeneration.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-62536-8

By:

Xie, Hao;
Ju, Huan;
Lu, Jing;
Wang, Xing;
Peng, Hui

Publication type:

Article

Retinal and choroidal efficacy of switching treatment to faricimab in recalcitrant neovascular age related macular degeneration.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-59632-0

By:

Eckardt, Franziska;
Lorger, Anna;
Hafner, Michael;
Klaas, Julian Elias;
Schworm, Benedikt;
Kreutzer, Thomas Christian;
Priglinger, Siegfried Georg;
Siedlecki, Jakob

Publication type:

Article

Aflibercept Versus Bevacizumab as First-Line Therapy in Age-Related Macular Degeneration.

Published in:

Current Health Sciences Journal, 2023, v. 49, n. 4, p. 503, doi. 10.12865/CHSJ.49.03.04

By:

SALAVAT, MĂDĂLINA-CASIANA PALFI;
ȘECLĂMAN, EDWARD PAUL;
MUȘAT, ANDREEA-ALEXANDRA;
BORUGĂ, MĂDĂLINA;
PATONI, CRISTINA;
POPESCU, MARIUS-NICOLAE;
TEODORESCU, OANA ELENA;
MUȘAT, OVIDIU;
PATONI, STELLA IOANA POPESCU

Publication type:

Article

Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis.

Published in:

Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1144422

By:

Xiao Xie;
Chao Lian;
Zhiping Zhang;
Meng Feng;
Wenqi Wang;
Xiaomeng Yuan;
Yanmei Shi;
Tingting Liu

Publication type:

Article

Visual Acuity Outcomes and Influencing Factors in a Cohort of UK Real-World Diabetic Macular Oedema Patients During the First Two Years of Anti-VEGF Treatment.

Published in:

Pharmaceutics, 2025, v. 17, n. 1, p. 99, doi. 10.3390/pharmaceutics17010099

By:

Wen, Qing;
Karcher, Helene;
Wright, David M.;
Sinha, Samriddhi Buxy;
Chakravarthy, Usha;
Santos, Catarina;
Igwe, Franklin;
Salongcay, Recivall;
Curran, Katie;
Peto, Tunde

Publication type:

Article